SANDIMMUN NEORAL sol buv 100 mg/ml 50 ml

7680526570169 CH-52657 L04AD01 07.15.0.

Active substances:

SANDIMMUN NEORAL sol buv 100 mg/ml 50 ml
SANDIMMUN NEORAL sol buv 100 mg/ml 50 ml
SANDIMMUN NEORAL sol buv 100 mg/ml 50 ml
1 / 3
google

Details

Product number
5265701
CPT
-
Packaging group
50
Unit
ml
Composition
ciclosporinum 100 mg, ethanolum anhydricum 94.7 mg, propylenglycolum 94.7 mg, interesterified corn oil, macrogolglyceroli hydroxystearas 383.7 mg, E 307, ad solutionem pro 1 ml corresp. ethanolum 12 % V/V.

Articles (1)

Sandimmun Neoral, Trinklösung
Trinklösung
50
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
ciclosporinum
100.0 MG Substance Wirkstoff (Principe actif)
ethanolum anhydricum
94.7 MG Substance HBESI
propylenglycolum
94.7 MG Substance HBESI
interesterified corn oil
- Substance HNIDK
macrogolglyceroli hydroxystearas
383.7 MG Substance HNIDK
E 307
- Substance ANTOX

Reimbursement information

Public price
CHF 205.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1995

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
52657
Drug name
Sandimmun Neoral, Trinklösung
Galenic form
LSOR
ATC Code
L04AD01
Authorization status
Z
Dispensation category
B
First authorization
16/05/1994
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Immunsuppressivum

Packaging details

Description (FR)
SANDIMMUN NEORAL sol buv 100 mg/ml 50 ml
Description (DE)
SANDIMMUN NEORAL Trink Lös 100 mg/ml 50 ml
Market launch
16/05/1994
Narcotic (BTM)
No
Buy us a coffee Explore the data